Need To Know: Analysts Are Much More Bullish On Leap Therapeutics, Inc. (NASDAQ:LPTX)

Leap Therapeutics, Inc. (NASDAQ:LPTX) shareholders will have a reason to smile today, with the analysts making substantial upgrades to next year's forecasts. Consensus estimates suggest investors could expect greatly increased statutory revenues and earnings per share, with the analysts modelling a real improvement in business performance.

Following the upgrade, the most recent consensus for Leap Therapeutics from its five analysts is for revenues of US$5.9m in 2021 which, if met, would be a major 422% increase on its sales over the past 12 months. Losses are predicted to fall substantially, shrinking 50% to US$0.42. Yet before this consensus update, the analysts had been forecasting revenues of US$3.5m and losses of US$0.59 per share in 2021. We can see there's definitely been a change in sentiment in this update, with the analysts administering a sizeable upgrade to next year's revenue estimates, while at the same time reducing their loss estimates.

See our latest analysis for Leap Therapeutics

The Bottom Line

The most important thing here is that analysts reduced their loss per share estimates for next year, reflecting increased optimism around Leap Therapeutics' prospects. More bullish expectations could be a signal for investors to take a closer look at Leap Therapeutics.

These earnings upgrades look like a sterling endorsement, but before diving in - you should know that we've spotted 6 potential flags with Leap Therapeutics, including major dilution from new stock issuance in the past year. For more information, you can click through to our platform to learn more about this and the 4 other flags we've identified .

Another way to search for interesting companies that could be reaching an inflection point is to track whether management are buying or selling, with our free list of growing companies that insiders are buying.

If you’re looking to trade Leap Therapeutics, open an account with the lowest-cost* platform trusted by professionals, Interactive Brokers. Their clients from over 200 countries and territories trade stocks, options, futures, forex, bonds and funds worldwide from a single integrated account. Promoted

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
^*Interactive Brokers Rated Lowest Cost Broker by StockBrokers.com Annual Online Review 2020

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com.